B57.42

Clinical Causes: Reactivation of latent Trypanosoma cruzi infection, especially in immunocompromised individuals such as those with HIV/AIDS or undergoing immunosuppressive therapy. Transmission through reactivation of chronic infection, often in endemic areas, or less commonly through congenital transmission or organ transplantation.

Key Symptoms: Headache, often severe Altered mental status or confusion Fever and malaise Seizures Weakness or paralysis on one or more sides of the body Neck stiffness Sensitivity to light (photophobia) Visual disturbances

Diagnosis Path: Neuroimaging: MRI or CT scans to identify brain inflammation or lesions. Lumbar puncture: Analysis of cerebrospinal fluid (CSF) revealing increased white blood cells and protein levels, and possibly detection of Trypanosoma cruzi through microscopy or PCR. Serological tests: Detection of antibodies against Trypanosoma cruzi in blood samples. Blood tests: To evaluate overall health and immune system status.

Treatment Protocols: Antiparasitic medications: Such as benznidazole or nifurtimox, to target Trypanosoma cruzi. Supportive care: Including monitored hydration, pain management, and seizure control if necessary. Corticosteroids: May be used to reduce brain inflammation and manage cerebral edema. Monitoring and treating complications: Such as increased intracranial pressure or secondary infections. Addressing underlying immunosuppression: Optimizing immune function to prevent reactivation.